SONIDEGIB

SONIDEGIB was reported 1679 times

SONIDEGIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LEUCINE AMINOPEPTIDASE DECREASED 1 0.3333
1 RHINOSCLEROMA 2 0.2222
2 POSITIVE DOSE RESPONSE RELATIONSHIP 1 0.1429
3 APOLIPOPROTEIN A-I INCREASED 1 0.1111
4 APOLIPOPROTEIN INCREASED 1 0.1000
5 SQUAMOUS CELL CARCINOMA OF THE PAROTID GLAND 1 0.0526
6 MALIGNANT RENAL HYPERTENSION 1 0.0500
7 BLOOD CANNABINOIDS INCREASED 1 0.0417
8 ORBITAL HAEMORRHAGE 1 0.0323
9 ARTERIAL GRAFT 1 0.0323
10 MYOGLOBIN URINE 1 0.0303
11 ELECTROCARDIOGRAM ST SEGMENT 1 0.0278
12 TRIPLE NEGATIVE BREAST CANCER 17 0.0253
13 EPIPHYSEAL FRACTURE 1 0.0250
14 CORNEAL IRRITATION 2 0.0250
15 HAEMOGLOBIN URINE 1 0.0233
16 EPIPHYSEAL DISORDER 1 0.0222
17 AORTIC ELONGATION 1 0.0172
18 TYMPANOPLASTY 1 0.0137
19 PERIORBITAL INFECTION 1 0.0123
20 PULMONARY BULLA 1 0.0118
21 ALPHA HYDROXYBUTYRATE DEHYDROGENASE INCREASED 1 0.0116
22 AUTOIMMUNE ENTEROPATHY 1 0.0114
23 CUTANEOUS TUBERCULOSIS 2 0.0110
24 SARS-COV-2 TEST 1 0.0105
25 PANCREATIC ENZYMES ABNORMAL 1 0.0102
26 HERNIA PERFORATION 1 0.0102
27 ANORECTAL POLYP 1 0.0093
28 CREATINE KINASE INCREASED 6 0.0078
29 BLOOD CREATINE PHOSPHOKINASE 1 0.0068
30 MEDULLOBLASTOMA 1 0.0067
31 BASOSQUAMOUS CARCINOMA 1 0.0067
32 FACIAL OPERATION 1 0.0062
33 ADNEXA UTERI CYST 1 0.0062
34 ALOPECIA TOTALIS 2 0.0061
35 UROBILINOGEN URINE INCREASED 1 0.0061
36 RADIATION SKIN INJURY 7 0.0060
37 SWELLING OF NOSE 1 0.0058
38 ACQUIRED GENE MUTATION 7 0.0053
39 TREATMENT DELAYED 9 0.0052
40 URINARY CASTS 2 0.0051
41 TONGUE HAEMATOMA 1 0.0051
42 HAEMOGLOBIN 1 0.0050
43 URINARY OCCULT BLOOD POSITIVE 1 0.0043
44 TUMOUR ULCERATION 1 0.0042
45 CANCER SURGERY 4 0.0042
46 ELECTROCARDIOGRAM P WAVE ABNORMAL 1 0.0041
47 NEUROENDOCRINE CARCINOMA METASTATIC 1 0.0041
48 ELECTROLYTE DEPLETION 2 0.0041
49 ANORECTAL INFECTION 1 0.0040
50 PARAPARESIS 7 0.0039
51 INTESTINAL MALROTATION 1 0.0038
52 PERCUTANEOUS CORONARY INTERVENTION 1 0.0035
53 MALIGNANT NEOPLASM OF EYE 1 0.0035
54 PREMATURE AGEING 1 0.0034
55 RESTRICTIVE CARDIOMYOPATHY 1 0.0033
56 LITHIASIS 1 0.0033
57 EPIPHYSES PREMATURE FUSION 1 0.0033
58 AGEUSIA 82 0.0033
59 C-REACTIVE PROTEIN DECREASED 2 0.0031
60 FAECAL OCCULT BLOOD POSITIVE 1 0.0028
61 MYOGLOBIN BLOOD INCREASED 4 0.0026
62 GASTRODUODENAL ULCER 1 0.0024
63 URINARY TRACT INFECTION STAPHYLOCOCCAL 1 0.0023
64 HYPERLEUKOCYTOSIS 2 0.0023
65 MUSCLE ENZYME INCREASED 1 0.0023
66 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 1 0.0022
67 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 1 0.0022
68 TASTE DISORDER 45 0.0022
69 CHRONIC GASTRITIS 5 0.0022
70 BLOOD CREATINE PHOSPHOKINASE INCREASED 63 0.0022
71 HYPOPROTEINAEMIA 4 0.0021
72 THERAPY RESPONDER 1 0.0020
73 SEPSIS SYNDROME 1 0.0020
74 URETEROLITHIASIS 2 0.0019
75 MYOGLOBINURIA 1 0.0019
76 LEFT ATRIAL ENLARGEMENT 1 0.0019
77 BLOOD IMMUNOGLOBULIN A INCREASED 1 0.0019
78 THERAPY CESSATION 82 0.0016
79 HYPOTRICHOSIS 1 0.0016
80 NASAL CRUSTING 1 0.0015
81 BASAL CELL CARCINOMA 24 0.0015
82 TUMOUR PAIN 2 0.0015
83 NEOPLASM RECURRENCE 5 0.0015
84 PEPTIC ULCER HAEMORRHAGE 1 0.0014
85 PERFORATED ULCER 1 0.0013
86 ELECTROCARDIOGRAM T WAVE ABNORMAL 2 0.0013
87 EXPOSURE VIA BODY FLUID 1 0.0013
88 OSTEOSCLEROSIS 2 0.0013
89 MUSCLE SPASMS 230 0.0013
90 URETERIC STENOSIS 1 0.0012
91 HEPATITIS VIRAL 1 0.0012
92 SKIN TOXICITY 7 0.0012
93 POST-TRAUMATIC NECK SYNDROME 1 0.0012
94 PYLORIC STENOSIS 1 0.0012
95 MUSCLE FATIGUE 5 0.0012
96 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
97 OESOPHAGEAL OBSTRUCTION 1 0.0012
98 FOOD REFUSAL 1 0.0011
99 SALIVA ALTERED 1 0.0011
100 HUMAN CHORIONIC GONADOTROPIN INCREASED 1 0.0011
101 SOFT TISSUE INFECTION 2 0.0011
102 MUSCLE SWELLING 1 0.0011
103 BLOOD UREA ABNORMAL 1 0.0011
104 HEPATIC MASS 2 0.0010
105 HYPOGEUSIA 2 0.0010
106 MASTOIDITIS 1 0.0010
107 CELL DEATH 2 0.0010
108 LIGHT CHAIN ANALYSIS INCREASED 1 0.0010
109 SKIN SENSITISATION 1 0.0010
110 SQUAMOUS CELL CARCINOMA 9 0.0010
111 TUMOUR NECROSIS 1 0.0009
112 FEBRILE BONE MARROW APLASIA 4 0.0009
113 GALLBLADDER ENLARGEMENT 1 0.0009
114 SARCOMA 1 0.0009
115 ESCHERICHIA BACTERAEMIA 2 0.0008
116 LACUNAR INFARCTION 2 0.0008
117 INFECTED CYST 1 0.0008
118 REFLUX GASTRITIS 1 0.0008
119 DIABETES INSIPIDUS 2 0.0008
120 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
121 HELICOBACTER GASTRITIS 1 0.0008
122 INTERVERTEBRAL DISC OPERATION 1 0.0008
123 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
124 ENDOCRINE DISORDER 1 0.0008
125 EXPOSURE VIA FATHER 1 0.0008
126 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
127 ANAL HAEMORRHAGE 2 0.0007
128 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
129 DUODENAL ULCER 5 0.0007
130 NECK MASS 2 0.0007
131 INTENSIVE CARE 1 0.0007
132 POST HERPETIC NEURALGIA 1 0.0007
133 NOROVIRUS INFECTION 1 0.0007
134 ALOPECIA 136 0.0007
135 NONINFECTIVE GINGIVITIS 1 0.0007
136 FOOT AMPUTATION 1 0.0007
137 DYSGEUSIA 51 0.0007
138 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
139 BILIARY DILATATION 1 0.0007
140 GENERALISED ANXIETY DISORDER 1 0.0007
141 ANGIOPLASTY 1 0.0007
142 GASTRITIS HAEMORRHAGIC 1 0.0007
143 THERAPY INTERRUPTED 47 0.0007
144 NEURITIS 1 0.0006
145 NEOPLASM SKIN 1 0.0006
146 PNEUMONIA LEGIONELLA 1 0.0006
147 ACUTE LEUKAEMIA 1 0.0006
148 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
149 METASTASES TO SPINE 2 0.0006
150 SPLEEN DISORDER 1 0.0006
151 FOOD AVERSION 1 0.0006
152 ALOPECIA AREATA 1 0.0006
153 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
154 TETANY 1 0.0005
155 VENTRICULAR ARRHYTHMIA 2 0.0005
156 PNEUMONIA KLEBSIELLA 1 0.0005
157 CARDIAC DYSFUNCTION 2 0.0005
158 LIPASE INCREASED 4 0.0005
159 NEOPLASM 6 0.0005
160 PURULENCE 1 0.0005
161 PRODUCT USE ISSUE 96 0.0005
162 JOINT NOISE 1 0.0005
163 THERAPY CHANGE 5 0.0005
164 EAR HAEMORRHAGE 1 0.0005
165 INTENTIONAL DOSE OMISSION 14 0.0005
166 HYPERURICAEMIA 2 0.0005
167 LUNG ABSCESS 1 0.0005
168 DISEASE PROGRESSION 56 0.0005
169 OPTIC NEUROPATHY 1 0.0005
170 SHOULDER OPERATION 2 0.0005
171 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
172 LANGUAGE DISORDER 1 0.0005
173 PARONYCHIA 2 0.0005
174 APPETITE DISORDER 3 0.0005
175 BLOOD CREATINE INCREASED 2 0.0005
176 PARESIS 1 0.0004
177 THERAPY PARTIAL RESPONDER 7 0.0004
178 MADAROSIS 5 0.0004
179 BILIRUBIN CONJUGATED INCREASED 1 0.0004
180 HAEMATOLOGICAL INFECTION 1 0.0004
181 CARTILAGE INJURY 1 0.0004
182 PERSECUTORY DELUSION 1 0.0004
183 HYDRONEPHROSIS 3 0.0004
184 CACHEXIA 2 0.0004
185 AORTIC ARTERIOSCLEROSIS 1 0.0004
186 BLOOD CHLORIDE DECREASED 1 0.0004
187 HYPOALBUMINAEMIA 3 0.0004
188 MYALGIA 65 0.0004
189 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
190 SHOULDER ARTHROPLASTY 1 0.0004
191 MUSCLE DISORDER 3 0.0004
192 GASTRIC ULCER 7 0.0004
193 SKIN WRINKLING 1 0.0004
194 OESOPHAGITIS 4 0.0004
195 GASTRIC ULCER HAEMORRHAGE 2 0.0004
196 SCAB 4 0.0004
197 HEART VALVE INCOMPETENCE 1 0.0003
198 LIP PAIN 1 0.0003
199 SKIN ATROPHY 2 0.0003
200 ANOSMIA 5 0.0003
201 HYPOVOLAEMIA 2 0.0003
202 MALIGNANT NEOPLASM PROGRESSION 35 0.0003
203 NECK INJURY 1 0.0003
204 GROWTH RETARDATION 1 0.0003
205 CARDIAC PACEMAKER INSERTION 2 0.0003
206 MYOSITIS 3 0.0003
207 CRANIOCEREBRAL INJURY 1 0.0003
208 EATING DISORDER 7 0.0003
209 IRON DEFICIENCY ANAEMIA 3 0.0003
210 DEVICE RELATED INFECTION 5 0.0003
211 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
212 HYPERCALCAEMIA 4 0.0003
213 BRAIN DEATH 1 0.0003
214 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 23 0.0003
215 ABDOMINAL ADHESIONS 1 0.0003
216 IRIDOCYCLITIS 1 0.0003
217 TESTICULAR PAIN 1 0.0003
218 HEPATITIS B REACTIVATION 1 0.0003
219 LIVER ABSCESS 1 0.0003
220 HYPOVENTILATION 1 0.0003
221 LISTLESS 1 0.0003
222 NEAR DEATH EXPERIENCE 1 0.0003
223 PRODUCT DOSE OMISSION ISSUE 89 0.0003
224 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
225 PEPTIC ULCER 1 0.0003
226 DECREASED APPETITE 70 0.0003
227 HYPOTONIA 3 0.0003
228 NEPHRITIS 1 0.0003
229 PRODUCT ADMINISTRATION ERROR 6 0.0003
230 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
231 DIABETIC RETINOPATHY 1 0.0003
232 DISEASE RECURRENCE 14 0.0003
233 REGURGITATION 1 0.0003
234 WEIGHT DECREASED 81 0.0003
235 DROOLING 2 0.0003
236 BLOOD CREATININE ABNORMAL 1 0.0003
237 LARGE INTESTINE POLYP 2 0.0003
238 FEBRILE NEUTROPENIA 19 0.0003
239 MACULOPATHY 1 0.0003
240 APPENDICECTOMY 1 0.0003
241 METASTASIS 2 0.0003
242 BONE LESION 1 0.0003
243 MAJOR DEPRESSION 2 0.0003
244 AMYLASE INCREASED 1 0.0003
245 CHROMATURIA 6 0.0003
246 PROTEIN TOTAL DECREASED 1 0.0003
247 PAROSMIA 2 0.0003
248 CATHETER SITE INFECTION 1 0.0003
249 LOSS OF CONTROL OF LEGS 1 0.0003
250 TROPONIN INCREASED 2 0.0003
251 HAEMATURIA 9 0.0003
252 OESOPHAGEAL DISORDER 1 0.0003
253 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
254 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
255 LUNG INFECTION 4 0.0003
256 ACUTE MYELOID LEUKAEMIA 4 0.0003
257 HYPERKALAEMIA 9 0.0003
258 CERVIX CARCINOMA 1 0.0003
259 WOUND SECRETION 1 0.0003
260 SKIN ODOUR ABNORMAL 1 0.0003
261 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
262 FURUNCLE 2 0.0003
263 BLOOD ALBUMIN DECREASED 2 0.0003
264 SKIN PAPILLOMA 1 0.0002
265 RECURRENT CANCER 1 0.0002
266 RHABDOMYOLYSIS 10 0.0002
267 URINARY RETENTION 8 0.0002
268 BUNDLE BRANCH BLOCK LEFT 1 0.0002
269 POOR PERIPHERAL CIRCULATION 1 0.0002
270 CARDIAC FAILURE CHRONIC 1 0.0002
271 HEPATIC PAIN 1 0.0002
272 MYOPATHY 2 0.0002
273 MUSCULAR WEAKNESS 26 0.0002
274 AMENORRHOEA 4 0.0002
275 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
276 EAR DISORDER 1 0.0002
277 MUSCLE TWITCHING 5 0.0002
278 SYNOVIAL CYST 1 0.0002
279 LOCALISED OEDEMA 1 0.0002
280 RENAL FUNCTION TEST ABNORMAL 1 0.0002
281 NON-SMALL CELL LUNG CANCER 1 0.0002
282 HERNIA 4 0.0002
283 STAPHYLOCOCCAL SEPSIS 1 0.0002
284 COLON CANCER 3 0.0002
285 HEPATIC ENZYME ABNORMAL 1 0.0002
286 SALIVARY HYPERSECRETION 2 0.0002
287 CORONARY ARTERY STENOSIS 1 0.0002
288 DRUG TOLERANCE 1 0.0002
289 FEEDING DISORDER 4 0.0002
290 DYSLIPIDAEMIA 1 0.0002
291 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 35 0.0002
292 FAILURE TO THRIVE 1 0.0002
293 C-REACTIVE PROTEIN INCREASED 7 0.0002
294 BRAIN FOG 3 0.0002
295 PRODUCT USE COMPLAINT 3 0.0002
296 SERUM FERRITIN INCREASED 1 0.0002
297 ASTHENIA 71 0.0002
298 RENAL PAIN 2 0.0002
299 RETCHING 4 0.0002
300 SKIN CANCER 4 0.0002
301 BLOOD CREATININE INCREASED 12 0.0002
302 HYDROCEPHALUS 1 0.0002
303 DEAFNESS UNILATERAL 1 0.0002
304 STREPTOCOCCAL INFECTION 1 0.0002
305 MYOCARDIAL ISCHAEMIA 2 0.0002
306 HYPERTONIA 1 0.0002
307 ENTEROCOLITIS 1 0.0002
308 METASTASES TO LUNG 2 0.0002
309 NEOPLASM PROGRESSION 6 0.0002
310 SEPSIS 19 0.0002
311 URINE ODOUR ABNORMAL 1 0.0002
312 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
313 THYROID CANCER 2 0.0002
314 PLATELET COUNT ABNORMAL 1 0.0002
315 LOCALISED INFECTION 4 0.0002
316 TREATMENT NONCOMPLIANCE 9 0.0002
317 INGUINAL HERNIA 1 0.0002
318 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
319 SMALL INTESTINAL OBSTRUCTION 2 0.0002
320 ILEUS 2 0.0002
321 HEPATIC FUNCTION ABNORMAL 6 0.0002
322 PNEUMONIA ASPIRATION 4 0.0002
323 FRACTURE 3 0.0002
324 FATIGUE 123 0.0002
325 ERECTILE DYSFUNCTION 4 0.0002
326 HEPATITIS ACUTE 1 0.0002
327 BRADYPHRENIA 1 0.0002
328 NEPHROLITHIASIS 7 0.0002
329 GASTRITIS 4 0.0002
330 WALKING AID USER 1 0.0002
331 CORONAVIRUS INFECTION 1 0.0002
332 CARDIAC FAILURE ACUTE 1 0.0001
333 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
334 ULCER HAEMORRHAGE 1 0.0001
335 ABNORMAL LOSS OF WEIGHT 1 0.0001
336 HAIR GROWTH ABNORMAL 1 0.0001
337 ABDOMINAL DISCOMFORT 24 0.0001
338 DYSPEPSIA 14 0.0001
339 PRODUCT SUPPLY ISSUE 1 0.0001
340 SUBDURAL HAEMATOMA 2 0.0001
341 DEATH 119 0.0001
342 FAECES SOFT 1 0.0001
343 RASH PUSTULAR 1 0.0001
344 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
345 TRANSAMINASES INCREASED 3 0.0001
346 URINARY TRACT INFECTION 23 0.0001
347 OFF LABEL USE 117 0.0001
348 HYPOAESTHESIA ORAL 2 0.0001
349 THERAPEUTIC RESPONSE DECREASED 8 0.0001
350 HAEMODYNAMIC INSTABILITY 1 0.0001
351 HYPOKALAEMIA 6 0.0001
352 ATRIOVENTRICULAR BLOCK 1 0.0001
353 LIMB DISCOMFORT 4 0.0001
354 EJECTION FRACTION DECREASED 2 0.0001
355 PELVIC FRACTURE 1 0.0001
356 MULTIPLE ALLERGIES 1 0.0001
357 DRUG-INDUCED LIVER INJURY 4 0.0001
358 HEAD INJURY 4 0.0001
359 TRICUSPID VALVE INCOMPETENCE 1 0.0001
360 GINGIVAL PAIN 1 0.0001
361 BLOOD DISORDER 1 0.0001
362 MYASTHENIA GRAVIS 1 0.0001
363 SHOCK HAEMORRHAGIC 1 0.0001
364 ABNORMAL FAECES 1 0.0001
365 METASTASES TO BONE 2 0.0001
366 IMPAIRED HEALING 4 0.0001
367 MUSCLE INJURY 1 0.0001
368 EMBOLISM 1 0.0001
369 SECOND PRIMARY MALIGNANCY 1 0.0001
370 HEMIPLEGIA 1 0.0001
371 FUNGAL INFECTION 4 0.0001
372 DEHYDRATION 16 0.0001
373 ILLNESS 12 0.0001
374 DYSPHAGIA 11 0.0001
375 MUSCLE STRAIN 1 0.0001
376 URINE OUTPUT DECREASED 1 0.0001
377 METASTASES TO LIVER 2 0.0001
378 NAUSEA 90 0.0001
379 HEAD DISCOMFORT 2 0.0001
380 CARDIAC FAILURE 9 0.0001
381 GASTROENTERITIS VIRAL 2 0.0001
382 OPTIC NEURITIS 1 0.0001
383 SKIN LESION 3 0.0001
384 RETINAL DETACHMENT 1 0.0001
385 OVARIAN CANCER 1 0.0001
386 DIVERTICULITIS 3 0.0001
387 INFLUENZA 12 0.0001
388 RENAL DISORDER 5 0.0001
389 FLANK PAIN 1 0.0001
390 ARTERIOSCLEROSIS 1 0.0001
391 INTESTINAL OBSTRUCTION 4 0.0001
392 HYPOCALCAEMIA 2 0.0001
393 HAEMORRHAGE 11 0.0001
394 MUSCULOSKELETAL DISORDER 2 0.0001
395 RECALLED PRODUCT ADMINISTERED 1 0.0001
396 INCREASED APPETITE 2 0.0001
397 HYPERCHOLESTEROLAEMIA 1 0.0001
398 SINUS BRADYCARDIA 1 0.0001
399 DIZZINESS POSTURAL 1 0.0001
400 PRODUCT STORAGE ERROR 9 0.0001
401 CHOKING 2 0.0001
402 DIARRHOEA 66 0.0001
403 VOMITING 48 0.0001
404 CONDITION AGGRAVATED 31 0.0001
405 BODY TEMPERATURE DECREASED 1 0.0001
406 OVARIAN CYST 1 0.0001
407 HEPATIC FAILURE 3 0.0001
408 GAIT DISTURBANCE 19 0.0001
409 EMPHYSEMA 1 0.0001
410 CORONARY ARTERY DISEASE 3 0.0001
411 DRUG LEVEL DECREASED 1 0.0001
412 RENAL FAILURE 13 0.0001
413 HYPERBILIRUBINAEMIA 1 0.0001
414 TOOTH LOSS 2 0.0001
415 VENTRICULAR EXTRASYSTOLES 1 0.0001
416 EYE DISCHARGE 1 0.0001
417 TENDERNESS 1 0.0001
418 PETECHIAE 1 0.0001
419 FOLLICULITIS 1 0.0001
420 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
421 HALLUCINATION, VISUAL 2 0.0001
422 FULL BLOOD COUNT ABNORMAL 1 0.0001
423 SUDDEN DEATH 1 0.0001
424 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
425 CYSTITIS 3 0.0001
426 HIP FRACTURE 3 0.0001
427 FALL 31 0.0001
428 BREAST CANCER METASTATIC 1 0.0001
429 ATRIAL FIBRILLATION 9 0.0001
430 PHARYNGITIS STREPTOCOCCAL 1 0.0001
431 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
432 ABDOMINAL PAIN UPPER 19 0.0001
433 SKIN LACERATION 1 0.0001
434 ACUTE KIDNEY INJURY 14 0.0001
435 GASTROINTESTINAL PAIN 1 0.0001
436 DENTAL CARIES 1 0.0001
437 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
438 VIRAL INFECTION 3 0.0001
439 HYPERTENSIVE CRISIS 1 0.0001
440 HEPATOTOXICITY 2 0.0001
441 ORAL PAIN 2 0.0001
442 NEPHROPATHY TOXIC 1 0.0001
443 THERAPY NON-RESPONDER 4 0.0001
444 EYE INFECTION 1 0.0001
445 HEART RATE IRREGULAR 2 0.0001
446 MITRAL VALVE INCOMPETENCE 1 0.0001
447 PRODUCT AVAILABILITY ISSUE 2 0.0001
448 MICTURITION URGENCY 1 0.0001
449 INTERNAL HAEMORRHAGE 1 0.0001
450 MYOCARDITIS 1 0.0001
451 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
452 ELECTROLYTE IMBALANCE 1 0.0001
453 HOSPITALISATION 13 0.0001
454 BLOOD IRON DECREASED 1 0.0001
455 CHOLECYSTITIS 1 0.0001
456 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
457 HYPERLIPIDAEMIA 1 0.0001
458 MUSCLE RIGIDITY 1 0.0001
459 POLYNEUROPATHY 1 0.0001
460 NEURALGIA 2 0.0001
461 CYTOPENIA 1 0.0001
462 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
463 HYPOAESTHESIA 12 0.0001
464 SYNCOPE 8 0.0001
465 MUSCULOSKELETAL STIFFNESS 7 0.0001
466 CARDIOVASCULAR DISORDER 2 0.0001
467 ANAEMIA 15 0.0001
468 HEPATIC CYTOLYSIS 1 0.0001
469 ROTATOR CUFF SYNDROME 1 0.0001
470 DRUG RESISTANCE 2 0.0001
471 SKIN ULCER 2 0.0001
472 PNEUMONIA 25 0.0001
473 RESPIRATORY TRACT INFECTION 2 0.0001
474 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
475 BEDRIDDEN 1 0.0001
476 PULMONARY CONGESTION 1 0.0001
477 SARS-COV-2 TEST POSITIVE 1 0.0001
478 PANCREATITIS 4 0.0001
479 ADVERSE REACTION 1 0.0001
480 PLATELET COUNT DECREASED 8 0.0001
481 QUALITY OF LIFE DECREASED 1 0.0001
482 BLOOD BILIRUBIN INCREASED 2 0.0001
483 SINUS CONGESTION 1 0.0001
484 PRODUCT TASTE ABNORMAL 1 0.0001
485 GINGIVAL BLEEDING 1 0.0001
486 ABDOMINAL PAIN 17 0.0001
487 PERIPHERAL COLDNESS 1 0.0001
488 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
489 APHONIA 1 0.0001
490 WOUND 2 0.0001
491 RENAL IMPAIRMENT 6 0.0001
492 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
493 FLATULENCE 4 0.0001
494 SINUS TACHYCARDIA 1 0.0001
495 PRURITUS 27 0.0001
496 ANGINA PECTORIS 2 0.0001
497 ARTHRALGIA 29 0.0001
498 BALANCE DISORDER 6 0.0001
499 DRUG INTERACTION 11 0.0001
500 HYPERTHYROIDISM 1 0.0001
501 GASTROENTERITIS 1 0.0001
502 BONE PAIN 4 0.0001
503 URINARY INCONTINENCE 2 0.0001
504 SKIN HAEMORRHAGE 1 0.0001
505 PULMONARY MASS 1 0.0001
506 BLOOD POTASSIUM DECREASED 2 0.0001
507 APHASIA 2 0.0001
508 LACRIMATION INCREASED 2 0.0001
509 DIZZINESS 33 0.0001
510 PLEURAL EFFUSION 4 0.0001
511 VERTIGO 4 0.0001
512 DRUG DISPENSING ERROR 1 0.0001
513 THYROID DISORDER 1 0.0001
514 LYMPHOMA 1 0.0001
515 FEMUR FRACTURE 2 0.0001
516 DELUSION 1 0.0001
517 COVID-19 11 0.0001
518 HYPOTHYROIDISM 2 0.0001
519 MOVEMENT DISORDER 2 0.0001
520 DRUG INTOLERANCE 6 0.0001
521 MUSCLE TIGHTNESS 1 0.0001
522 BLOOD POTASSIUM INCREASED 1 0.0001
523 STAPHYLOCOCCAL INFECTION 2 0.0001
524 SEIZURE 7 0.0001
525 VENTRICULAR TACHYCARDIA 1 0.0001
526 LIP SWELLING 2 0.0001
527 COAGULOPATHY 1 0.0001
528 BLOOD UREA INCREASED 1 0.0001
529 CONSTIPATION 13 0.0001
530 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
531 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
532 CANDIDA INFECTION 1 0.0001
533 PARANOIA 1 0.0001
534 DELIRIUM 2 0.0001
535 OEDEMA PERIPHERAL 7 0.0001
536 MUSCULOSKELETAL PAIN 3 0.0001
537 DEPRESSED MOOD 3 0.0001
538 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
539 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
540 DRUG ERUPTION 1 0.0001
541 GASTROINTESTINAL DISORDER 5 0.0001
542 GOUT 1 0.0001
543 TOOTHACHE 1 0.0001
544 DRUG EFFECT INCOMPLETE 2 0.0001
545 RESTLESS LEGS SYNDROME 1 0.0001
546 HYPERGLYCAEMIA 2 0.0001
547 NASOPHARYNGITIS 10 0.0001
548 BLOOD GLUCOSE ABNORMAL 1 0.0001
549 CONJUNCTIVITIS 1 0.0001
550 AGRANULOCYTOSIS 1 0.0001
551 PAIN 33 0.0001
552 BACTERIAL INFECTION 1 0.0001
553 HYPONATRAEMIA 3 0.0001
554 HEPATIC CIRRHOSIS 1 0.0001
555 CEREBROVASCULAR ACCIDENT 9 0.0001
556 HALLUCINATION 4 0.0001
557 BLOOD SODIUM DECREASED 1 0.0001
558 COLITIS 2 0.0001
559 NEUROPATHY PERIPHERAL 5 0.0001
560 SLEEP APNOEA SYNDROME 1 0.0001
561 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
562 LOWER LIMB FRACTURE 1 0.0001
563 EAR PAIN 1 0.0001
564 DYSPHONIA 3 0.0001
565 ORAL HERPES 1 0.0001
566 CHILLS 6 0.0001
567 KIDNEY INFECTION 1 0.0001
568 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
569 SINUS DISORDER 1 0.0001
570 HAEMATOCRIT DECREASED 1 0.0001
571 BLOOD PRESSURE ABNORMAL 1 0.0001
572 SPINAL FRACTURE 1 0.0000
573 HYPOTENSION 10 0.0000
574 FULL BLOOD COUNT DECREASED 1 0.0000
575 EXTRA DOSE ADMINISTERED 2 0.0000
576 BLINDNESS 2 0.0000
577 RIB FRACTURE 1 0.0000
578 CARDIAC ARREST 4 0.0000
579 PERITONITIS 1 0.0000
580 TREATMENT FAILURE 4 0.0000
581 POLLAKIURIA 2 0.0000
582 DRUG INEFFECTIVE 62 0.0000
583 JOINT INJURY 1 0.0000
584 RECTAL HAEMORRHAGE 2 0.0000
585 SWELLING FACE 3 0.0000
586 SEPTIC SHOCK 2 0.0000
587 PRODUCT DISPENSING ERROR 1 0.0000
588 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
589 ANGIOEDEMA 2 0.0000
590 LIVER DISORDER 2 0.0000
591 STEVENS-JOHNSON SYNDROME 1 0.0000
592 TOOTH DISORDER 1 0.0000
593 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
594 PANCREATITIS ACUTE 1 0.0000
595 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
596 NEUTROPENIA 6 0.0000
597 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
598 OROPHARYNGEAL PAIN 4 0.0000
599 BLOOD CHOLESTEROL INCREASED 2 0.0000
600 BURNING SENSATION 3 0.0000
601 OCULAR HYPERAEMIA 2 0.0000
602 PULMONARY EMBOLISM 4 0.0000
603 RASH ERYTHEMATOUS 2 0.0000
604 CONTUSION 4 0.0000
605 HYPOGLYCAEMIA 2 0.0000
606 LIVER INJURY 1 0.0000
607 BRONCHITIS 3 0.0000
608 MYOCARDIAL INFARCTION 7 0.0000
609 HEADACHE 25 0.0000
610 CELLULITIS 2 0.0000
611 HYPOPHAGIA 1 0.0000
612 HEPATITIS 1 0.0000
613 BACK PAIN 9 0.0000
614 ABDOMINAL DISTENSION 4 0.0000
615 DEAFNESS 1 0.0000
616 ARTHRITIS 3 0.0000
617 DRY SKIN 5 0.0000
618 CONFUSIONAL STATE 6 0.0000
619 DRY MOUTH 3 0.0000
620 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
621 HAEMATOCHEZIA 2 0.0000
622 RESPIRATORY DISTRESS 1 0.0000
623 HAEMOPTYSIS 1 0.0000
624 DEMENTIA 1 0.0000
625 THROMBOCYTOPENIA 4 0.0000
626 BLISTER 2 0.0000
627 EYE PAIN 2 0.0000
628 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
629 RED BLOOD CELL COUNT DECREASED 1 0.0000
630 SOMNOLENCE 7 0.0000
631 LETHARGY 2 0.0000
632 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
633 LIVER FUNCTION TEST ABNORMAL 1 0.0000
634 DYSSTASIA 1 0.0000
635 PALPITATIONS 4 0.0000
636 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
637 SURGERY 2 0.0000
638 ASCITES 1 0.0000
639 PAIN IN EXTREMITY 10 0.0000
640 LABORATORY TEST ABNORMAL 1 0.0000
641 HYPERTENSION 7 0.0000
642 STOMATITIS 2 0.0000
643 BLOOD PRESSURE INCREASED 5 0.0000
644 VISUAL IMPAIRMENT 4 0.0000
645 SWOLLEN TONGUE 1 0.0000
646 MIGRAINE 3 0.0000
647 MOOD SWINGS 1 0.0000
648 NIGHT SWEATS 1 0.0000
649 RHINORRHOEA 2 0.0000
650 CHOLELITHIASIS 1 0.0000
651 VISUAL ACUITY REDUCED 1 0.0000
652 SKIN DISORDER 1 0.0000
653 NEOPLASM MALIGNANT 2 0.0000
654 GAIT INABILITY 1 0.0000
655 EYE PRURITUS 1 0.0000
656 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
657 HEPATIC ENZYME INCREASED 2 0.0000
658 GASTRIC DISORDER 1 0.0000
659 VISION BLURRED 4 0.0000
660 MEMORY IMPAIRMENT 4 0.0000
661 HEART RATE DECREASED 1 0.0000
662 PANIC ATTACK 1 0.0000
663 MALAISE 12 0.0000
664 ACCIDENTAL OVERDOSE 1 0.0000
665 RESTLESSNESS 1 0.0000
666 DYSURIA 1 0.0000
667 EPISTAXIS 2 0.0000
668 CHRONIC KIDNEY DISEASE 2 0.0000
669 DIABETES MELLITUS 2 0.0000
670 PARAESTHESIA 4 0.0000
671 ABNORMAL BEHAVIOUR 1 0.0000
672 THROMBOSIS 2 0.0000
673 LUNG NEOPLASM MALIGNANT 1 0.0000
674 OSTEOPOROSIS 1 0.0000
675 URTICARIA 4 0.0000
676 WITHDRAWAL SYNDROME 1 0.0000
677 MENTAL DISORDER 1 0.0000
678 TACHYCARDIA 2 0.0000
679 COLITIS ULCERATIVE 1 0.0000
680 WEIGHT INCREASED 5 0.0000
681 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
682 ADVERSE DRUG REACTION 2 0.0000
683 DEPRESSION 5 0.0000
684 TINNITUS 1 0.0000
685 COGNITIVE DISORDER 1 0.0000
686 COUGH 6 0.0000
687 CARDIAC DISORDER 2 0.0000
688 BLOOD GLUCOSE INCREASED 4 0.0000
689 DYSPNOEA 12 0.0000
690 ARRHYTHMIA 1 0.0000
691 ANXIETY 6 0.0000
692 FEELING ABNORMAL 5 0.0000
693 INTERSTITIAL LUNG DISEASE 1 0.0000
694 PYREXIA 7 0.0000
695 HEART RATE INCREASED 2 0.0000
696 DRY EYE 1 0.0000
697 LEUKOPENIA 1 0.0000
698 FLUID RETENTION 1 0.0000
699 HAEMOGLOBIN DECREASED 2 0.0000
700 ERYTHEMA 4 0.0000
701 ECZEMA 1 0.0000
702 SPEECH DISORDER 1 0.0000
703 BRADYCARDIA 1 0.0000
704 DISTURBANCE IN ATTENTION 1 0.0000
705 RASH PRURITIC 1 0.0000
706 OEDEMA 1 0.0000
707 ARTHROPATHY 1 0.0000
708 MEDICATION ERROR 1 0.0000
709 PANCYTOPENIA 1 0.0000
710 OXYGEN SATURATION DECREASED 1 0.0000
711 NASAL CONGESTION 1 0.0000
712 CATARACT 1 0.0000
713 ILL-DEFINED DISORDER 1 0.0000
714 DISCOMFORT 1 0.0000
715 HYPERSENSITIVITY 3 0.0000
716 RASH 7 0.0000
717 LOSS OF CONSCIOUSNESS 2 0.0000
718 HYPERHIDROSIS 2 0.0000
719 AMNESIA 1 0.0000
720 PRODUCT DOSE OMISSION 1 0.0000
721 INFUSION RELATED REACTION 1 0.0000
722 BLOOD PRESSURE DECREASED 1 0.0000
723 INSOMNIA 4 0.0000
724 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
725 RESPIRATORY FAILURE 1 0.0000
726 UNDERDOSE 1 0.0000
727 HOT FLUSH 1 0.0000
728 UNEVALUABLE EVENT 1 0.0000
729 ACNE 1 0.0000
730 PERIPHERAL SWELLING 2 0.0000
731 CARDIAC FAILURE CONGESTIVE 1 0.0000
732 INFLUENZA LIKE ILLNESS 1 0.0000
733 TOXICITY TO VARIOUS AGENTS 2 0.0000
734 DEVICE ISSUE 1 0.0000
735 NO ADVERSE EVENT 2 0.0000
736 SUICIDAL IDEATION 1 0.0000
737 CHEST PAIN 2 0.0000
738 SWELLING 1 0.0000
739 FLUSHING 1 0.0000
740 CHEST DISCOMFORT 1 0.0000
741 SINUSITIS 1 0.0000
742 INCORRECT DOSE ADMINISTERED 2 0.0000
743 JOINT SWELLING 1 0.0000
744 PSORIASIS 1 0.0000
745 PRODUCT QUALITY ISSUE 1 0.0000
746 INFECTION 1 0.0000
747 DRUG DOSE OMISSION 1 0.0000
748 TREMOR 1 0.0000
749 OVERDOSE 1 0.0000